DEXTROSE INJECTION MARKET ANALYSIS

Dextrose Injection Market, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Oct 2020
Code : CMI1835
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Dextrose Injection Market - Restraint

Side effects caused by dextrose injection such as fever, infection at the site of injection, and blood clot at the site of injection, and voluntary product recall are major factors restraining growth of the dextrose injection market.

For instance, in February 2018, the U.S. Food and Drug Administration announced the recall of Hospira, Inc., a Pfizer company’s, one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.

Restraints & Challenges: